StockData
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

STRYKER CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$297.94+3.28 (+1.11%)

Close on Oct 19, 2026

Market cap
$115.00B
P/E (TTM)
30.9
Dividend yield
–

Earnings

Next report expected Oct 29, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 30, 2026After market close$6.60B$3.30$3.69
Q1 FY2026
Ended Mar 31, 2026
Apr 30, 2026After market close$6.00B$1.93$2.60
Q4 FY2025
Ended Dec 31, 2025
Jan 29, 2026After market close$7.20B$2.20$4.47
Q3 FY2025
Ended Sep 30, 2025
Oct 30, 2025After market close$6.10B$2.22$3.19
Q2 FY2025
Ended Jun 30, 2025
Jul 31, 2025After market close$6.00B$2.29$3.13
Q1 FY2025
Ended Mar 31, 2025
May 1, 2025After market close$5.90B$1.69$2.84
Q4 FY2024
Ended Dec 31, 2024
Jan 28, 2025After market close$6.40B$1.41$4.01
Q3 FY2024
Ended Sep 30, 2024
Oct 29, 2024After market close$5.50B$2.16$2.87
Q2 FY2024
Ended Jun 30, 2024
Jul 30, 2024After market close$5.40B$2.14$2.81
Q1 FY2024
Ended Mar 31, 2024
Apr 30, 2024After market close–––
Q4 FY2023
Ended Dec 31, 2023
Jan 30, 2024After market close–––

Company guidance

Outlook given with results on Jul 30, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
organic net sales growthnon-GAAPfull year 20268.3% to 9.3% growthNew
adjusted net earnings per diluted sharenon-GAAPfull year 2026$14.95 to $15.10Raised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Stryker filed with the SEC